JPM
JPMorgan Chase & Co.
JPM has lower modeled downside risk, despite its lower overall score.
TCBK
TriCo Bancshares
TCBK has a slight edge over JPM overall, supported by stronger valuation and stronger fundamentals.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
TCBK Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
TCBK's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like TCBK.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
TCBK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 10x | $43.55 | -16% |
| Fair | 12x | $53.64 | +4% |
| Current | 12x | $51.58 | — |
| Forward | 12x | $51.58 | — |
| Expensive | 14x | $60.04 | +16% |
Historical ranges are pointers, not guarantees.
TCBK has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
TCBK Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for TCBK, with profitability improving.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over TCBK on earnings, with more consistent year-over-year improvement.
TCBK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.44 | +3.2% |
| Q3 2026 | $4.30 | +21% |
| Q2 2026 | $4.16 | +22% |
| Q1 2026 | $3.94 | +15% |
| Q4 2025 | $3.70 | +6.9% |
| Q3 2025 | $3.56 | +6% |
| Q2 2025 | $3.40 | 0% |
| Q1 2025 | $3.43 | +4.6% |
| Q4 2024 | $3.46 | -1.7% |
TCBK earned $4.30 per share over the past year, up 21% from the year before.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the edge over TCBK on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM's operating margin was 40% last quarter, about level with the same quarter a year ago.
TCBK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $116.7M | +8.5% |
| Q2 2026 | $111.9M | +8% |
| Q1 2026 | $108.3M | +9.8% |
| Q4 2025 | $109.4M | +9% |
| Q3 2025 | $107.6M | +8.5% |
| Q2 2025 | $103.6M | +5.9% |
| Q1 2025 | $98.6M | +0.1% |
| Q4 2024 | $100.4M | -2.2% |
TCBK's revenue has grown year over year for seven quarters in a row: $117M last quarter, up 8.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 45% | +1.4 points |
| Q2 2026 | 41% | +4.9 points |
| Q1 2026 | 42% | +6.6 points |
| Q4 2025 | 43% | +3.8 points |
| Q3 2025 | 43% | +3.5 points |
| Q2 2025 | 37% | -3.5 points |
| Q1 2025 | 36% | -2.5 points |
| Q4 2024 | 39% | +3.3 points |
TCBK has the edge over JPM on profitability, with a higher operating margin.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
TCBK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $39.1M | -9.5% |
| Q2 2026 | $23.2M | -18% |
| Q1 2026 | $33M | +45% |
| Q4 2025 | $33.7M | +47% |
| Q3 2025 | $43.2M | +58% |
| Q2 2025 | $28.2M | -8.5% |
| Q1 2025 | $22.8M | -5.1% |
| Q4 2024 | $22.9M | -35% |
TCBK has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over TCBK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
TCBK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +11K shares |
| 1 year | -1.8% | -605K shares |
| 3 years | -3.6% | -1.2M shares |
| 5 years | +7.6% | +2.3M shares |
| Available history | +4.8% | +1.5M shares |
TCBK has 32M diluted shares, down 1.8% from a year ago, with $34M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $1.8M |
| Q1 2026 | $22.4M |
| Q4 2025 | $9.7M |
| Q3 2025 | $2.5M |
| Q2 2025 | $15.7M |
| Q1 2025 | $4.1M |
| Q4 2024 | $1.9M |
TCBK spent $34M buying back its own shares over the past year, up 40% from the year before.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
TCBK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.0x | Net Cash |
| Q2 2026 | -0.5x | Net Cash |
| Q1 2026 | -1.6x | Net Cash |
| Q4 2025 | -0.8x | Net Cash |
| Q3 2025 | -1.7x | Net Cash |
| Q2 2025 | -1.9x | Net Cash |
| Q1 2025 | -1.4x | Net Cash |
| Q4 2024 | -0.3x | Net Cash |
TCBK has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
TCBK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.7 | Neutral |
| Stochastic | 21.0 | Neutral |
TCBK's weekly RSI is 46 (neutral) and its Stochastic is 21 (neutral).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
TCBK PE vs Financial Services Sector
| Metric | TCBK | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.8% below |
| PE % | 40 | 63 | 23 pts below |
TCBK has the edge over JPM on valuation relative to its sector.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over TCBK on trend strength, trading above more of its moving averages.
TCBK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.2 | 1.1% below |
| 20 week MA | $54.4 | 5.1% below |
| 50 week MA | $51.5 | 0.2% above |
| 100 week MA | $46.9 | 10% above |
| 200 week MA | $43.1 | 20% above |
TCBK has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 20% above its 200-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.
TCBK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $40.8 | $34.5 | -15% |
| 2021 | $34.5 | $42.0 | +22% |
| 2022 | $42.0 | $50.5 | +20% |
| 2023 | $50.5 | $43.0 | -15% |
| 2024 | $43.0 | $44.0 | +2.5% |
| 2025 | $44.0 | $48.3 | +9.7% |
| 2026 YTD | $48.3 | $51.6 | +6.8% |
TCBK has the edge over JPM on returns for 2026, with the stronger performance.